Título: Trombocitopenia grave en lupus eritematoso generalizado: respuesta a diferentes
esquemas terapéuticos. Objetivo: Analizar la respuesta a los tratamientos para la …

En algunos casos la trombocitopenia secundaria a lupus eritematoso sistémico (LES) no
responde al tratamiento convencional. En los últimos años se ha reportado que el rituximab …

Objectives To describe the response and relapse of severe thrombocytopenia in patients
with systemic lupus erythematosus (SLE) with different treatments. Method We performed a …

Thrombocytopenia in patients with systemic lupus erythematosus (SLE) is associated with
higher morbidity and mortality. We report frequency, associations and short-term outcome of …

The aim of this presentation is to provide concise information regarding diagnosis and
management of immune mediated hematological manifestations of systemic lupus …

Introducción: la púrpura trombocitopénica inmune (PTI) es una manifestación hematológica
frecuente en el lupus eritematoso sistémico (LES). Los corticoesteroides son la primera …

Objectives: To clarify clinical manifestations, association with disease activity, and
prognostic impact of thrombocytopenia using simple and reliable indices. Methods: 632 …

Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by multi-
organ symptomatology. 16% of the patients with autoimmune thrombocytopenia have SLE …

Background: Severe and refractory immune thrombocytopenia (ITP) affects the life
expectancy of patients with systemic lupus erythematosus (SLE) and poses a challenge in …

OBJECTIVES: We aimed to characterise the frequency of thrombocytopenia in systemic
lupus erythematosus (SLE) and determine its time of onset during the course of the disease …